Drugs / DC/LNCaP-M1
last change Nov 2008 re-read 3 minutes ago

DC/LNCaP-M1

Developed for
prostate cancer
Investigated by
Rockefeller University

Trials 1

20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT00289341 Mar 2002 → Nov 2008 prostate cancer Rockefeller University Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DC/LNCaP-M1 “Subcutaneous injection of DC/LNCaP, DC/LNCaP-M1, DC/KLH” NCT00289341 ↗
Route Subcutaneous “Subcutaneous injection of DC/LNCaP, DC/LNCaP-M1, DC/KLH” NCT00289341 ↗